In agreement with this, the inhibition of STAT3 (Signal Transducer and Activator of Transcription 3) and p38 pathways promote DC differentiation in the tumor microenvironment and increased allogeneic T-cell reactivity against glioma, melanoma cells [106], or multiple myeloma [104]. The gene discussed is STAT3; the disease is glioma.